Single-cell profiling identifies pre-existing CD19-negative subclones in a B-ALL patient with CD19-negative relapse after CAR-T therapy | Nature Communications
CD19: a biomarker for B cell development, lymphoma diagnosis and therapy | Experimental Hematology & Oncology | Full Text
How To Identify B Cell Subsets Using Flow Cytometry
Treating B-cell cancer with T cells expressing anti-CD19 chimeric antigen receptors | Nature Reviews Clinical Oncology
Resources for CD 19 | Biomarker for normal and neplastic B cell | OriGene
Cells | Free Full-Text | Sensitivity and Specificity of CD19.CAR-T Cell Detection by Flow Cytometry and PCR
Screening for CD19-specific chimaeric antigen receptors with enhanced signalling via a barcoded library of intracellular domains | Nature Biomedical Engineering
Expression of a Novel Chimeric Inhibitory Receptor Attenuates CD19 CAR T Cells: A Promising Strategy for Toxicity Mitigation - Transplantation and Cellular Therapy, Official Publication of the American Society for Transplantation and
of CD19 and CD20 expression during B cell development. CD19 expression... | Download Scientific Diagram
B cells (mouse) | Miltenyi Biotec | USA
Frontiers | Memory B Cells in Multiple Sclerosis: Emerging Players in Disease Pathogenesis
B Cell Overview | Thermo Fisher Scientific - US
A Guide to Plasma Cell Markers | Biocompare: The Buyer's Guide for Life Scientists
Anti-CD19 chimeric antigen receptor T cells secreting anti-PD-L1 single-chain variable fragment attenuate PD-L1 mediated T cell inhibition - ScienceDirect